CRO Algorithme Pharma has partnered with Hôpital Maisonneuve-Rosemont (HMR). The HMR clinical research team includes over 60 clinicians and is supported by 75 employees and 75 graduate students and postgraduates. Together, they form an experienced network working in hematology, oncology, nephrology, ophthalmology and metabolic diseases.
“As sponsors look to obtain more information on their lead drug earlier in development, the need to include patient populations in early stage clinical trials continues to increase. Partnering with research teams who have experience in key therapeutic areas advances our goal of providing a full spectrum of phase I/IIa clinical research services to our diverse client base,” said Dr. Marc Lefebvre, vice president, scientific and regulatory affairs, Algorithme Pharma.